|
|
Article: Anacor Seeks $57.5M In IPO For Topical Boron-Based Pipeline.
- Article from:
- BIOWORLD Today
- Article date:
- September 5, 2007
- Author:
CopyrightCOPYRIGHT 2007 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Trista Morrison, Staff Writer
Anacor Pharmaceuticals Inc. capped off a busy month for IPO filings Friday, becoming the 10th biotech to file for an initial public offering in August.
Anacor's proposal to raise up to $57.5 million followed bids from ARYx Therapeutics Inc., Adnexus Therapeutics Inc., Insys Therapeutics Inc., Precision Therapeutics Inc., Biolex Inc., Nanosphere Inc., Peplin Inc., Reliant Pharmaceuticals Inc. and Genoptix Inc.
Proceeds from Anacor's offering will support the Palo Alto, Calif.-based company's development of topically-administered small molecules derived from its boron chemistry platform. A naturally occurring ...